Takeda Pharmaceutical Co. Ltd. · TSE:4502

Duprey Lauren Rusckowski received 45,140 Takeda Pharmaceutical Co. Ltd. shares as an award (Form 4)

Traded Jul 1, 2026 · Filed Jul 6, 2026

On Jul 1, 2026, Duprey Lauren Rusckowski (Chief Transformation Officer) received 45,140 Takeda Pharmaceutical Co. Ltd. shares as an award, leaving 273,643 shares. Filed Jul 6, 2026 (Form 4).

Awarded
45,140 shares
Holding after
273,643 shares
Trading plan
No
Role
Chief Transformation Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 1, 2026American Depositary SharesAward45,140273,643Direct

Source

View original at SEC

Related